Kalata-B13

General Information


DRACP ID  DRACP00747

Peptide Name   Kalata-B13

Sequence  GLPVCGETCFGGTCNTPGCACDPWPVCTRD

Sequence Length  30

UniProt ID  Not available

PubChem CID  Not available

Origin  Oldenlandia affinis

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
U-937/GTB Adult acute monocytic leukemia; Acute monoblastic/monocytic leukemia Leukemia IC50=3.8µM FMCA assay 72h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00747

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys5<--->Cys19; Cys9<--->Cys21; Cys14<--->Cys27; NCB: Gly1<--->Asp30

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C126H191N35O42S6

Absent amino acids  HIKMQSY

Common amino acids  C

Mass  357794

Pl  3.88

Basic residues  1

Acidic residues  3

Hydrophobic residues  6

Net charge  -2

Boman Index  -2359

Hydrophobicity  4

Aliphatic Index  35.67

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5875

Absorbance 280nm  202.59

Polar residues  16

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28669767

Title  Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra

Doi 10.1016/j.bbamem.2017.06.018

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.